MedTrace Logo

A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19）

NCT04425772 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 342

Last updated 2020-06-11

No results posted yet for this study

Summary

To evaluate the efficacy and safety of azvudine in treatment of COVID-19

Conditions

Interventions

DRUG

FNC+Standard of Care

FNC + Standard of Care according to the to the latest version of the National Health and Medical Commission Diagnostic criteria

DRUG

FNC dummy tablet+Standard of Care

FNC dummy tablet+ Standard of Care according to the to the latest version of the National Health and Medical Commission Diagnostic criteria

Sponsors & Collaborators

  • Henan Genuine Biotech Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-12
Primary Completion
2020-08-12
Completion
2020-08-12

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04425772 on ClinicalTrials.gov